Ruxolitinib is an effective steroid sparing agent in bronchiolitis obliterans due to chronic graft-versus-host-disease

Bone Marrow Transplant. 2020 Jun;55(6):1194-1196. doi: 10.1038/s41409-019-0662-6. Epub 2019 Sep 4.

¹ Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, 3901 Rainbow Blvd. MS 3007, Kansas City, KS, USA. cstreiler@kumc.edu.
² Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kansas, 3901 Rainbow Blvd. MS 3007, Kansas City, KS, USA.
³ University of Kansas School of Medicine, Kansas City, KS, USA.
⁴ Department of Hematologic Malignancies and Cellular Therapeutics, University of Kansas, Kansas City, KS, USA.

No abstract available

Publication types